Clinical Research Directory

Inclusion Criteria: * Patients aged 18 years or older. * The patient has been deemed by the HCP to change dressing to Mepilex® Border Flex. * Patients with chronic wounds (wounds that have not reduced in size by more than 40% to 50% or healed within a month) treated with foam dressings, other that Mepilex® Border Flex, according to its intended use at baseline visit for minimum 4 weeks. * Patients with an expectation of wound follow-up of at least 4 weeks. * Patients agree only to have the dressing changed by the HCP. * Patients capable of signing the Informed Consent Form and answer the questions being asked. Exclusion Criteria: * Patients with any applicable contraindication or sensibilization to any of the dressing compounds * Patients with pressure ulcers (PU) stage I, deep tissue injuries or terminal wounds (e.g., fungating wounds) * Patients with wounds whose location and/or aetiology requires a dressing change for reasons that are unrelated to the dressing characteristics such as wounds in the sacral area. * Hospice patients * Patients participating in other studies interfering with this study.